基本信息
浏览量:180
职业迁徙
个人简介
Characterizing the many modes of cell to cell communication through a multitude of neurotransmitters and receptors is crucial to further understanding the complexities of the central nervous system, both in health and disease.
Since the beginning of his tenure at the Douglas Institute Research Centre in 1983, Rémi Quirion, PhD, has cultivated a diverse laboratory and trained over 70 students and fellows, from all over the world, dedicated to the study of brain peptides (neuropeptide Y, CGRP), growth factors (nerve growth factor and insulin-like growth factor-1), and the role of programmed cell death in the pathogenesis of Alzheimer Disease and other neurodegenerative diseases.
In addition to being scientific director of the Douglas Institute Research Centre from 1996 to 2011, Rémi Quirion was the Inaugural Scientific Director of the Institute of Neurosciences, Mental Health and Addiction, one of the thirteen Canadian Institutes of Health Research (CIHR).
Work from Rémi Quirion's lab has helped to characterize the roles of cholinergic synapses in Alzheimer Disease, neuropeptide Y in depression and learning, and calcitonin gene-related peptide (CGRP) in pain and opioid tolerance.
In 2009, Rémi Quirion has joined Canadian Institutes of Health Research (CIHR) as Executive Director of the International Collaborative Research Strategy for Alzheimer's Disease.
Rémi Quirion left the Douglas institute in 2011 to become Quebec's first Chief Scientist.
Since the beginning of his tenure at the Douglas Institute Research Centre in 1983, Rémi Quirion, PhD, has cultivated a diverse laboratory and trained over 70 students and fellows, from all over the world, dedicated to the study of brain peptides (neuropeptide Y, CGRP), growth factors (nerve growth factor and insulin-like growth factor-1), and the role of programmed cell death in the pathogenesis of Alzheimer Disease and other neurodegenerative diseases.
In addition to being scientific director of the Douglas Institute Research Centre from 1996 to 2011, Rémi Quirion was the Inaugural Scientific Director of the Institute of Neurosciences, Mental Health and Addiction, one of the thirteen Canadian Institutes of Health Research (CIHR).
Work from Rémi Quirion's lab has helped to characterize the roles of cholinergic synapses in Alzheimer Disease, neuropeptide Y in depression and learning, and calcitonin gene-related peptide (CGRP) in pain and opioid tolerance.
In 2009, Rémi Quirion has joined Canadian Institutes of Health Research (CIHR) as Executive Director of the International Collaborative Research Strategy for Alzheimer's Disease.
Rémi Quirion left the Douglas institute in 2011 to become Quebec's first Chief Scientist.
研究兴趣
论文共 406 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
IUPHAR/BPS guide to pharmacology CITEno. 1 (2023)
引用0浏览0引用
0
0
JOURNAL OF PHARMACOLOGICAL SCIENCESno. SUPnan (2022): 1008623-225P
HAL (Le Centre pour la Communication Scientifique Directe) (2020)
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn